Summary:
To address drug shortages and concerns about quality, industry experts say Congress should consider steps such as improving hospital incentives and revising purchasing contracts.
Mounting drug shortages and supply chain vulnerabilities are putting patient care at risk in hospitals across the nation. As experts sound the alarm in Congress, questions grow about the safety, cost, and reliability of vital medicines. What concrete steps can policymakers and industry leaders take to secure America’s pharmaceutical future? Read on to discover the proposals and debates shaping the path forward.
Source: Senate Committee Examines Ways to Strengthen the Supply Chain for Hospital Drugs, Nick Hut, HFMA, October 13,2025; https://www.hfma.org/operations-management/senate-committee-examines-ways-to-strengthen-the-supply-chain-for-hospital-drugs/ .
Topics
Quality Improvement
Healthcare Process
Environmental Influences
Related
Inside the Battle for the Future of Addiction MedicineWhen the Doctor Needs a CheckupA Clinical Care Pathway to Provide Value-Based Care to Patients Hospitalized with CHF, COPD, and PneumoniaRecommended Reading
Quality and Risk
Inside the Battle for the Future of Addiction Medicine
Quality and Risk
When the Doctor Needs a Checkup
Quality and Risk
A Clinical Care Pathway to Provide Value-Based Care to Patients Hospitalized with CHF, COPD, and Pneumonia
Strategy and Innovation
Transforming Medical Leadership: Formulation of an 11-Competency Physician Leadership Model for Next-Generation Healthcare Leaders
Strategy and Innovation
Leonardo, Dragonflies, and Observation
Strategy and Innovation
What to Do When Your Senior Role Feels Totally Unsustainable